Drug Profile
Nolasiban - ObsEva
Alternative Names: Erlosiban; OBE-001Latest Information Update: 18 Jul 2023
Price :
$50
*
At a glance
- Originator Merck Serono
- Developer ObsEva
- Class Infertility therapies; Oximes; Pyrrolidinones; Small molecules; Tocolytics
- Mechanism of Action Oxytocin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Female infertility; Preterm labour